Company insight
The postbiotic from Japan for your gut microbiome
In a culture obsessed with all things ‘biotic’, postbiotics have long been overlooked. As Mitsubishi Corporation Life Sciences Europe is set to bring its postbiotic L-137 to the European market, the company highlights some of the potential benefits and the versatility of this exciting ingredient.
D
eveloped and produced in Japan, heat-killed Lactobacillus plantarum (L-137) is brought to the European market by House Wellness Foods and Mitsubishi Corporation Life Sciences Europe. Defined as a ‘postbiotic’, the ingredient enters the market at a time when there is increased interest in the gut microbiome and the role that ‘biotics’ can play in this field. More research is pointing to the complex relationship between gut health and the immune system, cognitive health and its potential link with diseases. Pre-, pro- and postbiotics are all terms that are often used interchangeably, but they refer to distinct elements of the digestive
process. The relationship between the ‘biotics’ is a critical one, as each component plays a crucial role in maintaining the health and function of the gut microbiome.
The key benefits of L-137 Postbiotics offer an interesting alternative or even addition to pre- and probiotics. L-137 specifically has characteristics that offer exciting opportunities for new product development. L-137 is a unique ingredient that was first isolated from a fermented fish and rice dish from Japan called narezushi. The specific L-137 strain stood out due to its ability to modulate the immune system. A key benefit of L-137 is that it is highly stable
in high temperatures and acidic conditions. This makes it possible to develop products that require heat treatment, such as UHT treatment for shelf stable drinks, or use in fruit juices with a lower pH level. This offers possibilities to create new product formats that are ‘good for gut health’, maintain immune system and even promote skin health in wide array of product formats. It is also worth noting that studies show synergies between L-137 and vitamins C, E and beta-glucans. This means it may be possible to use official EFSA Health claims in products that utilise this synergy. ●
www.mclseurope.com
healthy microbiome? Our specialty!
Supporting a Immunity
Postbiotic from Japan
on
Ingredients Insight /
www.ingredients-insight.com 31
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90
